Literature DB >> 16731426

Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference.

Neil Binkley1, John P Bilezikian, David L Kendler, Edward S Leib, E Michael Lewiecki, Steven M Petak.   

Abstract

The International Society for Clinical Densitometry (ISCD) convenes a Position Development Conference (PDC) every two years for the purpose of making recommendations on clinically relevant issues in bone densitometry. Topics for consideration are developed by the ISCD Scientific Advisory Committee and the PDC Steering Committee. Clinically relevant questions related to each topic area are assigned to subcommittees for a comprehensive medical literature review and presentation of a report to an international panel of experts. The expert panel includes representatives of the American Society for Bone and Mineral Research (ASBMR) and the International Osteoporosis Foundation (IOF). The recommendations of the PDC expert panel are evaluated by the ISCD Board of Directors, and those that are approved become Official Positions of the ISCD. The Official Positions have subsequently been endorsed by the ASBMR and IOF. The most recent PDC was held July 15-17, 2005, in Vancouver, BC, Canada. Topics considered included technical standardization, vertebral fracture assessment, and application of the 1994 World Health Organization (WHO) criteria to various skeletal sites and to populations other than postmenopausal white women. This report describes the methodology of the 2005 PDC and presents a summary of all ISCD Official Positions.

Entities:  

Mesh:

Year:  2006        PMID: 16731426     DOI: 10.1016/j.jocd.2006.05.002

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  31 in total

1.  Official positions of the International Society for Clinical Densitometry.

Authors:  E Michael Lewiecki; Neil Binkley; John P Bilezikian; David L Kendler; Edward S Leib; Steven M Petak
Journal:  Osteoporos Int       Date:  2006-08-18       Impact factor: 4.507

2.  Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry.

Authors:  E M Lewiecki; C M Gordon; S Baim; N Binkley; J P Bilezikian; D L Kendler; D B Hans; S Silverman; N J Bishop; M B Leonard; M-L Bianchi; H J Kalkwarf; C B Langman; H Plotkin; F Rauch; B S Zemel
Journal:  Osteoporos Int       Date:  2008-07-17       Impact factor: 4.507

3.  Prevalence of osteoporosis in the Korean population based on Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2011.

Authors:  Eun Jung Park; Il Woo Joo; Myoung-Jin Jang; Young Taek Kim; Kyungwon Oh; Han Jin Oh
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

4.  Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.

Authors:  Susan L Greenspan; Joel B Nelson; Donald L Trump; Julie M Wagner; Megan E Miller; Subashan Perera; Neil M Resnick
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

5.  Vitamin D levels and bone mass in rheumatoid arthritis.

Authors:  María L Brance; Lucas R Brun; Susana Lioi; Ariel Sánchez; Marcelo Abdala; Beatriz Oliveri
Journal:  Rheumatol Int       Date:  2014-07-01       Impact factor: 2.631

6.  Oral health behaviors and bone mineral density in South Korea: the 2008-2010 Korean National Health and Nutrition Examination Survey.

Authors:  Hyun-Jin Kim; Yang-Hyun Kim; Kyung-Hwan Cho; Byoung-Duck Han; Seon-Mee Kim; Youn-Seon Choi; Do-Hoon Kim; Kyung-Do Han; Yong-Joo Lee; Chul-Min Kim
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

7.  Prevalence of osteoporosis in men aged 65-75 in a primary care setting. A practice audit after application of the Canadian 2010 guidelines for osteoporosis screening.

Authors:  Robert Ferrari
Journal:  Clin Rheumatol       Date:  2014-04-30       Impact factor: 2.980

8.  Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression.

Authors:  N Binkley; S L Silverman; C Simonelli; N Santiago; J D Kohles; G Dasic; J A Sunyecz
Journal:  Osteoporos Int       Date:  2009-01-15       Impact factor: 4.507

9.  Association of coronary aortic calcium with abdominal aortic calcium detected on lateral dual energy x-ray absorptiometry spine images.

Authors:  John T Schousboe; Diane Claflin; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2009-06-06       Impact factor: 2.778

Review 10.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; N Burlet; C Cooper; P D Delmas; J-Y Reginster; F Borgstrom; R Rizzoli
Journal:  Osteoporos Int       Date:  2008-02-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.